Step 1 topics → Neurology and Special Senses → Migraine Pharmacotherapy

Migraine Pharmacotherapy

USMLE Step 1 trap: Misidentifies triptans as non-serotonergic agents rather than 5-HT1B/1D agonists. Triptans are 5-HT1B/1D agonists that cause vasoconstriction of meningeal vessels and inhibit trigeminal nociceptive transmission, secondarily reducing CGRP release.

Migraine pharmacotherapy splits cleanly into two categories: acute (abortive) treatment and preventive therapy. USMLE Step 1 tests both, but the high-yield trap is confusing which drugs go where and why. The classic acute agents are triptans (sumatriptan), ergotamine, NSAIDs, and antiemetics like metoclopramide. Preventive agents are a completely different list — propranolol, topiramate, valproate, amitriptyline, and the newer CGRP monoclonal antibodies like erenumab. If you mix these up, you'll mismanage a vignette every time.

The exam loves to test triptans from multiple angles: their mechanism (5-HT1B/1D agonism), their contraindications (cardiovascular disease, uncontrolled hypertension, prior stroke), and their interaction with MAOIs causing serotonin syndrome. A common misconception is that triptans work via a CGRP-specific or non-serotonergic mechanism — probably because CGRP is so heavily discussed in migraine pathophysiology. Don't fall for it. Triptans are serotonin agonists first; CGRP reduction is downstream. USMLE Step 1 will give you a patient who gets a triptan and then also takes an SSRI or MAOI — you need to recognize the serotonin syndrome risk.

For prevention, the exam tests indications and drug class logic. Propranolol (beta-blocker) is first-line. Topiramate and valproate are antiepileptics that double as migraine prophylaxis — but valproate is teratogenic, so a reproductive-age woman should get topiramate or propranolol instead. Amitriptyline (TCA) is especially useful when comorbid depression or insomnia is present. Erenumab and other CGRP antibodies are tested as the newest class, used when others fail. Knowing why each agent is chosen — and when it's contraindicated — is what separates a passing from a high-scoring answer.

From real student decks
54%have cards covering this topic
32%have mature cards

Common misconceptions

Common mistake
Wrong: Triptans work by blocking CGRP release through a non-serotonergic mechanism.
Right: Triptans are 5-HT1B/1D agonists that cause vasoconstriction of meningeal vessels and inhibit trigeminal nociceptive transmission, secondarily reducing CGRP release.
Triptans are 5-HT1B/1D agonists — their primary action is serotonergic. They constrict meningeal blood vessels via 5-HT1B receptors and block trigeminal pain transmission via 5-HT1D receptors on nerve terminals. CGRP release is reduced as a downstream consequence of that receptor activation, not through a separate CGRP-specific mechanism. Confusing triptans with CGRP antagonists like erenumab is a common exam error because both target migraine pathophysiology — but through entirely different receptor classes.
Common mistake
Wrong: Triptans are safe to use in patients with a history of coronary artery disease.
Right: Triptans are contraindicated in coronary artery disease, uncontrolled hypertension, and prior stroke due to their vasoconstrictive effects.
Triptans cause vasoconstriction, which is therapeutic in meningeal vessels but dangerous in already-compromised coronary or cerebral vasculature. In patients with CAD, uncontrolled hypertension, or prior stroke or TIA, this vasoconstrictive effect can precipitate myocardial infarction or cerebrovascular events. Always screen the vignette for cardiovascular history before selecting a triptan — the exam will give you a migraine patient with 'chest tightness' or a cardiac history specifically to test whether you catch this contraindication.
Common mistake
Wrong: Triptans can be used as daily preventive therapy for migraine.
Right: Migraine prevention uses agents such as propranolol, topiramate, valproate, amitriptyline, or CGRP monoclonal antibodies; triptans are only for acute treatment.
Triptans have no role in daily preventive therapy — they're purely abortive agents used at the onset of an attack. Using triptans too frequently actually causes medication overuse headache (rebound headache), which is the opposite of prevention. Preventive therapy uses entirely different drug classes: propranolol, topiramate, valproate, amitriptyline, or CGRP monoclonal antibodies. The exam will describe a patient with frequent migraines and ask what to add to their regimen — the answer will always come from the prevention list, never a triptan.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Acute migraine management: Know which drugs treat an active migraine attack (triptans, ergotamine, NSAIDs, antiemetics), their mechanisms, and when each is contraindicated — especially cardiovascular contraindications to triptans.
  2. Migraine prevention: Know the drug classes used for prophylaxis (beta-blockers, antiepileptics, TCAs, CGRP monoclonal antibodies), the clinical scenarios that favor each, and which agents are off-limits in specific patient populations (e.g., valproate in pregnancy).

Can you avoid these mistakes?

A 42-year-old man with a history of stable angina presents during an acute migraine. Which first-line abortive agent is contraindicated, and what would you use instead?
A 28-year-old woman with migraines more than 4 times per month asks about preventive therapy. She is trying to conceive. Which preventive agents are appropriate, and which should be avoided and why?
A patient taking phenelzine (an MAOI) for depression develops a severe migraine. Why is sumatriptan dangerous in this context, and what is the mechanism of the adverse effect?
A drug rep describes a new injectable agent that reduces migraine frequency by blocking the CGRP receptor. What drug class is this, and how does its mechanism differ from that of triptans, which also reduce CGRP activity?

Related topics

Primary Headaches (Migraine, Tension, Cluster) Neural Tube Formation and Derivatives Neural Crest Derivatives Neural Tube Defects Other Developmental Malformations

See how your Anki deck covers this topic.

Upload your deck for a free audit →